A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-60192-8
Affiliations:
25
Authors:
23
Go to article
Institutions Authors Share
University of Birmingham, United Kingdom (UK)
8.500000
 0.37
The Francis Crick Institute, United Kingdom (UK)
3.000000
 0.13
King Faisal Specialist Hospital and Research Centre (KFSH&RC), Saudi Arabia
2.000000
 0.09
Umm Al-Qura University, Saudi Arabia
2.000000
 0.09
La Fe University Hospital, Spain
1.500000
 0.07
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)
1.000000
 0.04
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain
0.666667
 0.03
Al-Baha University, Saudi Arabia
0.500000
 0.02
Jazan University, Saudi Arabia
0.500000
 0.02
Boston University (BU), United States of America (USA)
0.500000
 0.02
Boston Medical Center (BMC), United States of America (USA)
0.500000
 0.02
Murdoch Children's Research Institute (MCRI), Australia
0.500000
 0.02
Institute of Health Carlos III (ISCIII), Spain
0.366667
 0.02
Spanish National Cancer Research Centre (CNIO), Spain
0.200000
 0.01
Centre for Energy, Environment and Technology (CIEMAT), Spain
0.200000
 0.01
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain
0.200000
 0.01
Biomedical Research Networking Center on Rare Diseases (CIBERER), Spain
0.200000
 0.01
Josep Carreras Leukaemia Research Institute (IJC), Spain
0.166667
 0.01
Catalan Institution for Research and Advanced Studies (ICREA), Spain
0.166667
 0.01
University of Barcelona (UB), Spain
0.166667
 0.01
Sant Joan de Déu Research Institute (IRSJD), Spain
0.166667
 0.01
Interested in Oncology and Carcinogenesis?